News & Blog

News & Blog

| Apr 24 2025

Inhibition of the TLR4 receptor prevents neuro-inflammation and degeneration in frataxin-deficient sensory neurons

| Apr 7 2025

Characterization of ocular phenotype of the YG8-800 mouse model of FA and retinal-targeted treatment by AAV based CRISPR-Cas9 gene editing

| Mar 24 2025

Unraveling Epigenetic Mechanisms and Therapeutic Strategies for FXN Silencing in Friedreich’s Ataxia

| Mar 23 2024

Paired Prime Editors to treat Friedreich’s Ataxia

| Mar 19 2024

Treatment of Friedreich’s ataxia using novel ferroptosis inhibitors

| Mar 1 2024

Developing and delivering of novel gene editing technologies to contract GAA repeats in Friedreich’s ataxia

| Mar 20 2023

An optimized deep learning-based method for cerebellum segmentation

| Mar 19 2023

Mechanism of repeat expansion in Friedreich’s ataxia

| Mar 19 2023

An induced pluripotent stem cell model to investigate microglia in Friedreich Ataxia

| Mar 19 2023

Repeat associated non-AUG (RAN) proteins in FA: contribution to disease and therapeutic opportunities

| Mar 20 2022

LEOPARD-FA: Longitudinal Endpoint Optimization to Provide an Assessment of Relevant Drugs in Friedreich’s Ataxia

| Mar 19 2022

Understanding ketogenesis in FRDA: Pathophysiology, biomarkers and nutritional therapies